Safety first, a harmful interaction between rivaroxaban and berberine

Intern Med J. 2022 May;52(5):887-888. doi: 10.1111/imj.15774.

Authors

Mark Bonnichsen^{1

2}, Ted Stoklosa¹, David Bowen^{1

2}, Avik Majumdar^{1

2}

Affiliations

¹ AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
² Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

PMID: 35538009
DOI: 10.1111/imj.15774

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / adverse effects
Atrial Fibrillation*
Berberine*
Factor Xa Inhibitors / adverse effects
Humans
Rivaroxaban / adverse effects
Stroke*

Substances

Anticoagulants
Factor Xa Inhibitors
Berberine
Rivaroxaban